Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

COPENHAGEN BODY EXTREMES ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.5% 7.0% 5.6% 5.0% 5.0% 7.8% 20.2% 19.8%   Credit score (0-100)   42 34 39 43 43 31 6 6   Credit rating   BBB BBB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,682 1,665 1,734 1,786 2,022 1,763 0.0 0.0   EBITDA   55.3 46.6 96.0 103 156 81.1 0.0 0.0   EBIT   55.3 46.6 96.0 81.6 114 38.5 0.0 0.0   Pre-tax profit (PTP)   19.8 7.5 55.7 46.2 76.9 -32.3 0.0 0.0   Net earnings   15.3 5.9 43.5 36.0 60.0 -25.8 0.0 0.0   Pre-tax profit without non-rec. items   19.8 7.5 55.7 46.2 76.9 -32.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 191 149 106 0.0 0.0   Shareholders equity total   1,450 1,456 1,500 1,536 1,596 270 144 144   Interest-bearing liabilities   0.0 0.0 0.0 0.8 9.8 1,313 0.0 0.0   Balance sheet total (assets)   1,810 2,218 2,156 2,070 2,088 1,883 144 144   Net Debt   -269 -721 -282 -130 -165 1,106 -144 -144     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,682 1,665 1,734 1,786 2,022 1,763 0.0 0.0   Gross profit growth   18.7% -1.0% 4.1% 3.0% 13.3% -12.8% -100.0% 0.0%   Employees   5 5 5 5 5 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,810 2,218 2,156 2,070 2,088 1,883 144 144   Balance sheet change%   0.1% 22.5% -2.8% -4.0% 0.9% -9.8% -92.4% 0.0%   Added value   55.3 46.6 96.0 103.2 135.1 81.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 170 -85 -85 -106 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.3% 2.8% 5.5% 4.6% 5.6% 2.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.5% 2.4% 4.4% 3.9% 5.5% 2.0% 0.0% 0.0%   ROI %   4.3% 3.3% 6.5% 5.4% 7.2% 2.4% 0.0% 0.0%   ROE %   1.0% 0.4% 2.9% 2.4% 3.8% -2.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   84.0% 68.9% 75.0% 77.7% 77.9% 14.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -485.5% -1,549.0% -294.1% -126.4% -105.7% 1,363.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.1% 0.6% 486.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 8,346.1% 689.1% 10.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.5 1.2 1.4 0.9 0.8 0.2 0.0 0.0   Current Ratio   2.5 1.7 1.9 1.8 2.1 0.5 0.0 0.0   Cash and cash equivalent   268.7 721.3 282.4 131.3 174.9 207.3 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   525.6 531.6 575.0 425.7 528.6 -758.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   11 9 19 21 27 16 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   11 9 19 21 31 16 0 0   EBIT / employee   11 9 19 16 23 8 0 0   Net earnings / employee   3 1 9 7 12 -5 0 0